Public drug program spending share for seniors in Canada by top drug classes 2022

This statistic displays the distribution of the top 10 drug classes in Canada by public drug program spending on seniors in 2022. In that year, 2.6 percent of total drug program spending for seniors in Canada was dedicated to HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol.

本统计数据展示了2022年加拿大公共药物项目针对老年人用药支出中，前十大药物类别的分布情况。在该年度，加拿大老年人药物项目总支出中，2.6%用于HMG-CoA还原酶抑制剂（他汀类药物），此类药物常用于治疗高胆固醇。